Institutional Ownership
Zenas Biopharma Inc
CUSIP 98937LAA3NOTE 2.500% 4/0Q1 2026
Earnings
Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).